Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: PRRT (177Lu-Dotatate) is a therapeutic option for advanced NETs (neuroendocrine tumours). Systemic inflammatory parameters, such as NLR, PLR, SII, and other ratios derived from complete blood counts, are considered prognostic markers in NETs and other malignancies.
Conference:
Presenting Author: Maciejewski A
Authors: Maciejewski A, Komarnicki P, Musiałkiewicz J, Gut P, Ruchała M,
Keywords: neuroendocrine tumour, PRRT, systemic inflammatory parameter, PLR, prognostic biomarker,
#4549 Alpha-Fetoprotein as a valuable biomarker in neuroendocrine tumours
Introduction: Neuroendocrine tumours (NETs) are a rare group of tumours that pose a significant diagnostic, therapeutic, and prognostic challenge. This complexity arises from the diversity and heterogeneity of these neoplasms, as well as from the limitations of commonly used biomarkers in clinical practice. Alpha-fetoprotein (AFP) is a fetal protein widely used primarily for congenital defects in prenatal diagnostics and in certain malignancies in adults.
Conference:
Presenting Author:
Authors: Musiałkiewicz J, Gut P, Komarnicki P, Maciejewski A, Ruchała M,
Keywords: alpha-fetoprotein, biomarker, neuroendocrine tumour,
#4528 Serum visfatin concentration in metastatic pancreatic and midgut NETs: An exploratory study
Introduction: Neuroendocrine tumours (NETs) are commonly diagnosed at advanced stages due to their diverse and often asymptomatic clinical presentation. Visfatin, an adipocytokine involved in regulating cellular energy homeostasis, inflammation, and tumorigenesis, has been investigated as a potential biomarker in several neoplasms. However, its role in NETs remains unexplored.
Conference:
Presenting Author:
Authors: Komarnicki P, Maciejewski A, Musiałkiewicz J, Mastorakos G, Gut P,
Keywords: visfatin, biomarker, nicotinamide phosphoribosyltransferase, NAMPT, PBEF, eNAMPT,
Introduction: The NETest 2.0 is a PCR assay of circulating mRNA, scored 0-100. It has been developed as a biomarker to diagnose neuroendocrine neoplasia (NEN) and to provide tumour prognostic information.
Conference:
Presenting Author: Chirindel A
Authors: Chirindel A, Wild D, Voegeli M, de Dosso S, Siebenhüner A,
Keywords: NETest, tumour biomarker, NEN, disease presence, disease progression,
Introduction: Extrapulmonary (EP) mixed neuroendocrine/non-neuroendocrine neoplasms (MiNENs) are rare cancers with a dismal prognosis. The gene mutation profiles are incompletely understood.
Conference:
Presenting Author: Spada F
Authors: Spada F, Pisa E, Ranghiero A, Frassoni S, Bagnardi V,
Keywords: MiNEN, NGS, ESCAT, chemotherapy,